Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Smoking Cessation | 44 | 2023 | 2056 | 3.130 |
Why?
|
Buprenorphine | 9 | 2022 | 656 | 1.900 |
Why?
|
Opioid-Related Disorders | 11 | 2024 | 2164 | 1.370 |
Why?
|
Smoking | 25 | 2022 | 9053 | 1.090 |
Why?
|
HIV Infections | 31 | 2023 | 17351 | 0.950 |
Why?
|
Counseling | 19 | 2022 | 1547 | 0.810 |
Why?
|
Tobacco Use Disorder | 9 | 2018 | 703 | 0.750 |
Why?
|
Tobacco Smoke Pollution | 7 | 2020 | 819 | 0.720 |
Why?
|
Inpatients | 9 | 2020 | 2548 | 0.690 |
Why?
|
Alcoholism | 2 | 2020 | 1973 | 0.650 |
Why?
|
Patient Discharge | 17 | 2022 | 3443 | 0.650 |
Why?
|
Warfarin | 8 | 2020 | 1483 | 0.540 |
Why?
|
Telephone | 8 | 2020 | 627 | 0.520 |
Why?
|
Salvia | 1 | 2015 | 13 | 0.500 |
Why?
|
Substance-Related Disorders | 6 | 2023 | 4420 | 0.490 |
Why?
|
Behavior, Addictive | 1 | 2020 | 462 | 0.480 |
Why?
|
Patient Education as Topic | 9 | 2020 | 2319 | 0.470 |
Why?
|
Health Promotion | 6 | 2022 | 2214 | 0.460 |
Why?
|
Nigeria | 9 | 2023 | 770 | 0.450 |
Why?
|
Sarcoma, Kaposi | 3 | 2021 | 374 | 0.430 |
Why?
|
CD4 Lymphocyte Count | 9 | 2016 | 2571 | 0.410 |
Why?
|
Opiate Substitution Treatment | 5 | 2024 | 444 | 0.390 |
Why?
|
Hospitalization | 13 | 2020 | 10723 | 0.380 |
Why?
|
Motivation | 4 | 2015 | 2006 | 0.380 |
Why?
|
Emigrants and Immigrants | 2 | 2016 | 543 | 0.380 |
Why?
|
Medication Adherence | 3 | 2020 | 2176 | 0.380 |
Why?
|
Choroid Neoplasms | 3 | 2001 | 177 | 0.360 |
Why?
|
Bupropion | 3 | 2020 | 304 | 0.360 |
Why?
|
Anti-HIV Agents | 6 | 2020 | 4527 | 0.350 |
Why?
|
Anti-Retroviral Agents | 4 | 2018 | 1784 | 0.350 |
Why?
|
Nicotine | 3 | 2013 | 680 | 0.340 |
Why?
|
Adult | 75 | 2024 | 221177 | 0.340 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2011 | 625 | 0.330 |
Why?
|
Naltrexone | 2 | 2022 | 317 | 0.320 |
Why?
|
Parents | 8 | 2020 | 3563 | 0.320 |
Why?
|
Occupational Health | 2 | 2012 | 806 | 0.310 |
Why?
|
HIV Seropositivity | 2 | 2013 | 960 | 0.300 |
Why?
|
Boston | 17 | 2024 | 9326 | 0.300 |
Why?
|
Ambulatory Care Facilities | 4 | 2020 | 935 | 0.300 |
Why?
|
Female | 94 | 2024 | 392644 | 0.290 |
Why?
|
Male | 85 | 2024 | 360804 | 0.290 |
Why?
|
Medical Informatics | 1 | 2014 | 733 | 0.280 |
Why?
|
Humans | 125 | 2024 | 761504 | 0.280 |
Why?
|
Middle Aged | 66 | 2024 | 220895 | 0.270 |
Why?
|
Continuity of Patient Care | 5 | 2017 | 1069 | 0.270 |
Why?
|
Community Health Centers | 2 | 2024 | 461 | 0.260 |
Why?
|
Patient Readmission | 1 | 2020 | 3270 | 0.260 |
Why?
|
Anticoagulants | 8 | 2020 | 4812 | 0.260 |
Why?
|
Atrial Fibrillation | 5 | 2020 | 5127 | 0.250 |
Why?
|
Physicians | 3 | 2014 | 4591 | 0.250 |
Why?
|
Program Development | 3 | 2022 | 1297 | 0.250 |
Why?
|
Mass Screening | 8 | 2019 | 5428 | 0.250 |
Why?
|
Community Health Services | 3 | 2020 | 656 | 0.240 |
Why?
|
Motor Activity | 1 | 2014 | 2715 | 0.230 |
Why?
|
Risk Reduction Behavior | 1 | 2010 | 1112 | 0.230 |
Why?
|
Mobile Health Units | 2 | 2015 | 92 | 0.220 |
Why?
|
Ambulatory Care | 4 | 2024 | 2775 | 0.220 |
Why?
|
Referral and Consultation | 7 | 2022 | 3600 | 0.210 |
Why?
|
Hospitals, General | 4 | 2023 | 798 | 0.210 |
Why?
|
Automobiles | 2 | 2013 | 111 | 0.210 |
Why?
|
Aftercare | 4 | 2022 | 914 | 0.200 |
Why?
|
South Africa | 8 | 2017 | 1842 | 0.200 |
Why?
|
Weight Gain | 1 | 2012 | 2348 | 0.200 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2016 | 1897 | 0.190 |
Why?
|
Hemorrhage | 5 | 2008 | 3424 | 0.190 |
Why?
|
Cohort Studies | 18 | 2024 | 41487 | 0.190 |
Why?
|
Endorphins | 1 | 2021 | 74 | 0.190 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2020 | 942 | 0.190 |
Why?
|
Tobacco Use Cessation | 1 | 2022 | 94 | 0.190 |
Why?
|
Pediatrics | 5 | 2015 | 3589 | 0.190 |
Why?
|
Diffusion of Innovation | 1 | 2006 | 728 | 0.180 |
Why?
|
Methadone | 1 | 2023 | 321 | 0.180 |
Why?
|
Overweight | 1 | 2012 | 2417 | 0.180 |
Why?
|
Prevalence | 10 | 2022 | 15732 | 0.180 |
Why?
|
Obstetrics | 1 | 2008 | 665 | 0.180 |
Why?
|
Neoplasms | 9 | 2022 | 22170 | 0.180 |
Why?
|
Primary Health Care | 6 | 2020 | 4686 | 0.180 |
Why?
|
Temperance | 1 | 2020 | 87 | 0.180 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2016 | 4016 | 0.180 |
Why?
|
Hot Flashes | 2 | 2013 | 330 | 0.180 |
Why?
|
Methamphetamine | 1 | 2022 | 165 | 0.180 |
Why?
|
Viral Load | 4 | 2018 | 3332 | 0.180 |
Why?
|
Coagulants | 1 | 2020 | 45 | 0.180 |
Why?
|
Cotinine | 3 | 2020 | 206 | 0.170 |
Why?
|
Patient Selection | 4 | 2020 | 4244 | 0.170 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2001 | 231 | 0.170 |
Why?
|
Cardiovascular Diseases | 8 | 2018 | 15500 | 0.170 |
Why?
|
Eye Color | 1 | 1999 | 36 | 0.170 |
Why?
|
Factor VIIa | 1 | 2020 | 103 | 0.170 |
Why?
|
Electronic Health Records | 3 | 2022 | 4811 | 0.160 |
Why?
|
Attitude of Health Personnel | 2 | 2010 | 3889 | 0.160 |
Why?
|
Marijuana Smoking | 1 | 2022 | 258 | 0.160 |
Why?
|
Heroin | 1 | 2019 | 119 | 0.160 |
Why?
|
Hallucinogens | 1 | 2022 | 197 | 0.160 |
Why?
|
Hospitals, Teaching | 3 | 2012 | 1156 | 0.150 |
Why?
|
Behavior Therapy | 2 | 2022 | 879 | 0.150 |
Why?
|
Physician-Patient Relations | 3 | 2010 | 3249 | 0.150 |
Why?
|
Self Report | 5 | 2019 | 3724 | 0.150 |
Why?
|
Blood Coagulation Factors | 1 | 2020 | 365 | 0.150 |
Why?
|
Office Visits | 2 | 2016 | 595 | 0.140 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2020 | 410 | 0.140 |
Why?
|
Retrospective Studies | 17 | 2023 | 80636 | 0.140 |
Why?
|
Patient Acceptance of Health Care | 4 | 2016 | 3205 | 0.140 |
Why?
|
Alcohol-Related Disorders | 1 | 2019 | 238 | 0.140 |
Why?
|
Practice Guidelines as Topic | 2 | 2013 | 7390 | 0.140 |
Why?
|
Follow-Up Studies | 12 | 2024 | 39106 | 0.140 |
Why?
|
Plasma | 1 | 2020 | 586 | 0.140 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2020 | 662 | 0.140 |
Why?
|
Algorithms | 4 | 2014 | 14031 | 0.140 |
Why?
|
Massachusetts | 7 | 2020 | 8830 | 0.130 |
Why?
|
Colonoscopy | 1 | 2024 | 1394 | 0.130 |
Why?
|
Fentanyl | 1 | 2019 | 434 | 0.130 |
Why?
|
HIV | 3 | 2020 | 1582 | 0.130 |
Why?
|
Narcotic Antagonists | 1 | 2020 | 585 | 0.130 |
Why?
|
Cannabis | 1 | 2022 | 441 | 0.130 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 899 | 0.130 |
Why?
|
Attitude | 1 | 2020 | 775 | 0.130 |
Why?
|
Stroke | 6 | 2018 | 9757 | 0.130 |
Why?
|
Intention | 1 | 2018 | 347 | 0.130 |
Why?
|
Urban Health Services | 1 | 2016 | 177 | 0.120 |
Why?
|
Public Sector | 1 | 2017 | 267 | 0.120 |
Why?
|
Prenatal Care | 3 | 2008 | 1139 | 0.120 |
Why?
|
Workplace | 2 | 2012 | 863 | 0.120 |
Why?
|
Family Practice | 2 | 2010 | 512 | 0.120 |
Why?
|
Blood Glucose | 3 | 2012 | 6391 | 0.120 |
Why?
|
Aged | 30 | 2024 | 169289 | 0.120 |
Why?
|
Atrial Flutter | 1 | 2017 | 252 | 0.120 |
Why?
|
Young Adult | 19 | 2020 | 59243 | 0.120 |
Why?
|
Analgesics, Opioid | 5 | 2024 | 3808 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2022 | 10209 | 0.120 |
Why?
|
Intracranial Hemorrhages | 1 | 2020 | 822 | 0.120 |
Why?
|
Melanoma | 4 | 2001 | 5709 | 0.120 |
Why?
|
Feedback, Sensory | 1 | 2014 | 56 | 0.110 |
Why?
|
Blood Coagulation | 1 | 2020 | 1154 | 0.110 |
Why?
|
Time Factors | 12 | 2020 | 39967 | 0.110 |
Why?
|
Health Care Surveys | 3 | 2010 | 2426 | 0.110 |
Why?
|
Delivery of Health Care | 6 | 2020 | 5336 | 0.110 |
Why?
|
Internship and Residency | 1 | 2014 | 5880 | 0.110 |
Why?
|
Competitive Behavior | 1 | 2014 | 78 | 0.110 |
Why?
|
Quality of Health Care | 4 | 2010 | 4330 | 0.110 |
Why?
|
Kenya | 3 | 2021 | 758 | 0.110 |
Why?
|
Multivariate Analysis | 4 | 2015 | 12059 | 0.110 |
Why?
|
Reference Values | 3 | 2010 | 4920 | 0.110 |
Why?
|
Cholesterol | 2 | 2014 | 2904 | 0.110 |
Why?
|
Medically Underserved Area | 1 | 2015 | 254 | 0.110 |
Why?
|
Geographic Information Systems | 1 | 2015 | 281 | 0.110 |
Why?
|
Cancer Care Facilities | 1 | 2016 | 422 | 0.110 |
Why?
|
Viremia | 1 | 2016 | 707 | 0.110 |
Why?
|
Risk Factors | 14 | 2018 | 74206 | 0.110 |
Why?
|
User-Computer Interface | 2 | 2011 | 1400 | 0.110 |
Why?
|
Logistic Models | 6 | 2015 | 13255 | 0.100 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2007 | 3415 | 0.100 |
Why?
|
Hospitals | 3 | 2022 | 3882 | 0.100 |
Why?
|
Documentation | 2 | 2022 | 897 | 0.100 |
Why?
|
Pennsylvania | 3 | 2020 | 613 | 0.100 |
Why?
|
Medical Records Systems, Computerized | 2 | 2011 | 1192 | 0.100 |
Why?
|
Outpatients | 2 | 2024 | 1597 | 0.100 |
Why?
|
Aged, 80 and over | 16 | 2020 | 58976 | 0.100 |
Why?
|
Vitamin D Deficiency | 1 | 2021 | 1388 | 0.100 |
Why?
|
International Normalized Ratio | 3 | 2020 | 382 | 0.090 |
Why?
|
Treatment Outcome | 15 | 2022 | 64680 | 0.090 |
Why?
|
Hypoparathyroidism | 1 | 2012 | 136 | 0.090 |
Why?
|
Depressive Disorder, Major | 2 | 2022 | 4761 | 0.090 |
Why?
|
Emergency Service, Hospital | 2 | 2022 | 7879 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2001 | 2645 | 0.090 |
Why?
|
Reference Standards | 1 | 2014 | 1003 | 0.090 |
Why?
|
Self Medication | 1 | 2011 | 117 | 0.090 |
Why?
|
Health Plan Implementation | 1 | 2013 | 337 | 0.090 |
Why?
|
Mental Health Services | 1 | 2022 | 1730 | 0.090 |
Why?
|
Personnel, Hospital | 1 | 2012 | 285 | 0.090 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3201 | 0.090 |
Why?
|
Parent-Child Relations | 1 | 2014 | 761 | 0.080 |
Why?
|
Research Design | 3 | 2016 | 6180 | 0.080 |
Why?
|
Guideline Adherence | 2 | 2013 | 2220 | 0.080 |
Why?
|
Obesity | 2 | 2017 | 12947 | 0.080 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 26125 | 0.080 |
Why?
|
Education, Distance | 1 | 2013 | 261 | 0.080 |
Why?
|
Data Mining | 1 | 2014 | 551 | 0.080 |
Why?
|
Linear Models | 2 | 2016 | 5871 | 0.080 |
Why?
|
Thiophenes | 1 | 2013 | 569 | 0.080 |
Why?
|
Telemedicine | 3 | 2022 | 3051 | 0.080 |
Why?
|
Feasibility Studies | 3 | 2023 | 5247 | 0.080 |
Why?
|
Aspirin | 1 | 2020 | 3133 | 0.080 |
Why?
|
Monitoring, Physiologic | 2 | 2014 | 1779 | 0.080 |
Why?
|
Program Evaluation | 3 | 2015 | 2495 | 0.070 |
Why?
|
Adolescent | 19 | 2020 | 88319 | 0.070 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2013 | 1148 | 0.070 |
Why?
|
Data Collection | 2 | 2014 | 3322 | 0.070 |
Why?
|
Education, Medical, Continuing | 1 | 2013 | 823 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2012 | 12148 | 0.070 |
Why?
|
Nutrition Assessment | 1 | 2010 | 728 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1421 | 0.070 |
Why?
|
RNA, Viral | 1 | 2015 | 2846 | 0.070 |
Why?
|
Blood Pressure Determination | 1 | 2010 | 633 | 0.070 |
Why?
|
Incidence | 6 | 2020 | 21353 | 0.070 |
Why?
|
Depression | 3 | 2012 | 8124 | 0.070 |
Why?
|
Managed Care Programs | 3 | 2007 | 940 | 0.070 |
Why?
|
Therapy, Computer-Assisted | 1 | 2008 | 266 | 0.070 |
Why?
|
Health Surveys | 3 | 2012 | 4061 | 0.070 |
Why?
|
Health Policy | 3 | 2012 | 2684 | 0.070 |
Why?
|
Colorectal Neoplasms | 2 | 2024 | 6935 | 0.070 |
Why?
|
Marital Status | 1 | 2008 | 426 | 0.070 |
Why?
|
Physical Fitness | 1 | 2010 | 743 | 0.070 |
Why?
|
Multicenter Studies as Topic | 2 | 2022 | 1702 | 0.070 |
Why?
|
Prescription Fees | 1 | 2007 | 153 | 0.070 |
Why?
|
Drug Evaluation | 1 | 2007 | 641 | 0.060 |
Why?
|
Databases, Factual | 2 | 2018 | 7967 | 0.060 |
Why?
|
Health Behavior | 2 | 2019 | 2643 | 0.060 |
Why?
|
Prospective Studies | 10 | 2024 | 54425 | 0.060 |
Why?
|
Predictive Value of Tests | 4 | 2018 | 15266 | 0.060 |
Why?
|
Professional Practice | 1 | 2007 | 313 | 0.060 |
Why?
|
Cost-Benefit Analysis | 4 | 2022 | 5492 | 0.060 |
Why?
|
Menopause | 1 | 2013 | 1646 | 0.060 |
Why?
|
Body Composition | 1 | 2014 | 2426 | 0.060 |
Why?
|
Language | 1 | 2014 | 1540 | 0.060 |
Why?
|
Registries | 3 | 2017 | 8224 | 0.060 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2007 | 348 | 0.060 |
Why?
|
Parity | 1 | 2008 | 927 | 0.060 |
Why?
|
Depression, Postpartum | 1 | 2009 | 346 | 0.060 |
Why?
|
Patient Satisfaction | 4 | 2020 | 3461 | 0.060 |
Why?
|
Pandemics | 2 | 2021 | 8654 | 0.060 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2008 | 366 | 0.060 |
Why?
|
Student Health Services | 1 | 2003 | 40 | 0.060 |
Why?
|
United States | 12 | 2020 | 72334 | 0.060 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2006 | 489 | 0.060 |
Why?
|
Withholding Treatment | 1 | 2008 | 617 | 0.050 |
Why?
|
Occult Blood | 1 | 2024 | 198 | 0.050 |
Why?
|
Physician's Role | 1 | 2010 | 917 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2017 | 3049 | 0.050 |
Why?
|
Cerebral Hemorrhage | 1 | 2014 | 2656 | 0.050 |
Why?
|
Internal Medicine | 1 | 2010 | 1051 | 0.050 |
Why?
|
Medical Order Entry Systems | 1 | 2008 | 521 | 0.050 |
Why?
|
Students | 2 | 2003 | 1741 | 0.050 |
Why?
|
Delivery, Obstetric | 1 | 2010 | 940 | 0.050 |
Why?
|
Blood Pressure | 2 | 2018 | 8481 | 0.050 |
Why?
|
Angina, Unstable | 1 | 2006 | 888 | 0.050 |
Why?
|
Central Nervous System Agents | 1 | 2022 | 75 | 0.050 |
Why?
|
Radiography, Thoracic | 1 | 2008 | 1302 | 0.050 |
Why?
|
Pregnant Women | 1 | 2007 | 566 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9280 | 0.050 |
Why?
|
Anxiety Disorders | 1 | 2013 | 2720 | 0.050 |
Why?
|
Quality of Life | 3 | 2018 | 13367 | 0.050 |
Why?
|
Thromboembolism | 1 | 2008 | 995 | 0.050 |
Why?
|
Reminder Systems | 1 | 2024 | 388 | 0.050 |
Why?
|
Postpartum Period | 1 | 2008 | 1173 | 0.050 |
Why?
|
Antidepressive Agents | 1 | 2013 | 2897 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2020 | 5821 | 0.050 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2001 | 239 | 0.050 |
Why?
|
Weight Loss | 1 | 2012 | 2684 | 0.050 |
Why?
|
Smoke | 1 | 2022 | 235 | 0.040 |
Why?
|
Radiotherapy, High-Energy | 1 | 2001 | 228 | 0.040 |
Why?
|
Comparative Effectiveness Research | 2 | 2016 | 709 | 0.040 |
Why?
|
Tennessee | 1 | 2020 | 120 | 0.040 |
Why?
|
Pancreatic Cyst | 1 | 2004 | 367 | 0.040 |
Why?
|
Educational Status | 1 | 2008 | 2522 | 0.040 |
Why?
|
Anesthesiology | 1 | 2010 | 1117 | 0.040 |
Why?
|
Lost to Follow-Up | 1 | 2020 | 123 | 0.040 |
Why?
|
School Health Services | 1 | 2003 | 384 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2017 | 5440 | 0.040 |
Why?
|
Kinetics | 1 | 2007 | 6374 | 0.040 |
Why?
|
Fees and Charges | 1 | 2020 | 192 | 0.040 |
Why?
|
Cardiology | 1 | 2010 | 1656 | 0.040 |
Why?
|
Drug Costs | 1 | 2007 | 1183 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2015 | 20098 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 4915 | 0.040 |
Why?
|
Length of Stay | 1 | 2012 | 6425 | 0.040 |
Why?
|
Health Care Costs | 2 | 2012 | 3242 | 0.040 |
Why?
|
General Surgery | 1 | 2010 | 1692 | 0.040 |
Why?
|
Mothers | 1 | 2009 | 2198 | 0.040 |
Why?
|
Patient Dropouts | 1 | 2020 | 412 | 0.040 |
Why?
|
Child | 6 | 2020 | 80153 | 0.040 |
Why?
|
Anxiety | 1 | 2013 | 4573 | 0.040 |
Why?
|
HIV-1 | 1 | 2015 | 6863 | 0.040 |
Why?
|
Myocardial Infarction | 2 | 2010 | 11460 | 0.040 |
Why?
|
Protons | 2 | 2001 | 1116 | 0.040 |
Why?
|
Drug Prescriptions | 1 | 2007 | 1670 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2020 | 744 | 0.040 |
Why?
|
Regression Analysis | 2 | 2018 | 6343 | 0.040 |
Why?
|
Respiration, Artificial | 1 | 2008 | 2628 | 0.040 |
Why?
|
Disclosure | 1 | 2023 | 748 | 0.040 |
Why?
|
Socioeconomic Factors | 3 | 2017 | 7827 | 0.040 |
Why?
|
Blood Flow Velocity | 1 | 2001 | 1371 | 0.040 |
Why?
|
Botswana | 1 | 2020 | 1048 | 0.040 |
Why?
|
Prognosis | 4 | 2020 | 29625 | 0.030 |
Why?
|
Social Stigma | 1 | 2023 | 769 | 0.030 |
Why?
|
Uganda | 1 | 2021 | 1332 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15842 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2005 | 2064 | 0.030 |
Why?
|
Saliva | 1 | 2020 | 828 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 3357 | 0.030 |
Why?
|
Telemetry | 1 | 2017 | 199 | 0.030 |
Why?
|
Radiotherapy Dosage | 2 | 2000 | 2898 | 0.030 |
Why?
|
Heparin | 1 | 2003 | 1634 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12725 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 30052 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2020 | 1129 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2020 | 21012 | 0.030 |
Why?
|
Diabetes Mellitus | 2 | 2017 | 5840 | 0.030 |
Why?
|
Body Mass Index | 2 | 2010 | 12953 | 0.030 |
Why?
|
Analgesics | 1 | 2022 | 1070 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 10766 | 0.030 |
Why?
|
Clinical Competence | 1 | 2010 | 4792 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2014 | 12463 | 0.030 |
Why?
|
Pregnancy | 4 | 2009 | 29874 | 0.030 |
Why?
|
Age Factors | 4 | 2016 | 18395 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 4853 | 0.030 |
Why?
|
Heart Failure | 2 | 2017 | 11669 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2009 | 4481 | 0.030 |
Why?
|
Estrone | 1 | 2013 | 234 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2010 | 22176 | 0.030 |
Why?
|
Vitamins | 1 | 2021 | 1635 | 0.030 |
Why?
|
Health Expenditures | 2 | 2020 | 2366 | 0.030 |
Why?
|
Lens, Crystalline | 1 | 1995 | 389 | 0.030 |
Why?
|
Self Care | 1 | 2017 | 796 | 0.020 |
Why?
|
Leuprolide | 1 | 2013 | 312 | 0.020 |
Why?
|
Preventive Health Services | 1 | 2017 | 567 | 0.020 |
Why?
|
Automation | 1 | 2014 | 586 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2020 | 2208 | 0.020 |
Why?
|
Radiation Injuries | 2 | 2000 | 1189 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2017 | 771 | 0.020 |
Why?
|
Uveal Neoplasms | 1 | 1995 | 341 | 0.020 |
Why?
|
Risk Assessment | 4 | 2018 | 23995 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 1 | 2013 | 726 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1814 | 0.020 |
Why?
|
Luteinizing Hormone | 1 | 2013 | 820 | 0.020 |
Why?
|
Hospitals, Rural | 1 | 2012 | 176 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2012 | 500 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2850 | 0.020 |
Why?
|
Family Characteristics | 1 | 2015 | 1004 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2020 | 1998 | 0.020 |
Why?
|
Propensity Score | 1 | 2018 | 1913 | 0.020 |
Why?
|
Environment | 1 | 2016 | 1123 | 0.020 |
Why?
|
Dermatology | 1 | 2020 | 918 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2273 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 495 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2321 | 0.020 |
Why?
|
Vulnerable Populations | 1 | 2015 | 703 | 0.020 |
Why?
|
Drug Administration Routes | 1 | 2010 | 150 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2017 | 1835 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2020 | 2557 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11742 | 0.020 |
Why?
|
Medicare | 1 | 2007 | 6770 | 0.020 |
Why?
|
Thrombosis | 1 | 2003 | 2942 | 0.020 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 2008 | 114 | 0.020 |
Why?
|
Child Welfare | 1 | 2013 | 521 | 0.020 |
Why?
|
International Classification of Diseases | 1 | 2014 | 909 | 0.020 |
Why?
|
Cataract | 1 | 1995 | 832 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3358 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6766 | 0.020 |
Why?
|
Communicable Diseases | 1 | 2017 | 875 | 0.020 |
Why?
|
Medical Record Linkage | 1 | 2010 | 285 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2017 | 2199 | 0.020 |
Why?
|
Geography | 1 | 2010 | 656 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14605 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1792 | 0.020 |
Why?
|
Vitamin D | 1 | 2021 | 3303 | 0.020 |
Why?
|
Double-Blind Method | 3 | 2008 | 12341 | 0.020 |
Why?
|
Cost Savings | 1 | 2012 | 913 | 0.020 |
Why?
|
Polysomnography | 1 | 2013 | 1848 | 0.020 |
Why?
|
Sex Factors | 2 | 2014 | 10552 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11121 | 0.020 |
Why?
|
Estradiol | 1 | 2013 | 1937 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2004 | 5368 | 0.020 |
Why?
|
Comorbidity | 2 | 2012 | 10508 | 0.020 |
Why?
|
Psychological Tests | 1 | 2008 | 640 | 0.020 |
Why?
|
Demography | 1 | 2010 | 1648 | 0.020 |
Why?
|
Caregivers | 1 | 2017 | 2237 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14666 | 0.010 |
Why?
|
Urban Population | 1 | 2012 | 2036 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2017 | 2020 | 0.010 |
Why?
|
Emotions | 1 | 2016 | 2739 | 0.010 |
Why?
|
Postoperative Hemorrhage | 1 | 2008 | 415 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2010 | 2927 | 0.010 |
Why?
|
Blood Loss, Surgical | 1 | 2008 | 637 | 0.010 |
Why?
|
Electrocardiography | 1 | 2017 | 6377 | 0.010 |
Why?
|
Vitamin K | 1 | 2006 | 318 | 0.010 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2008 | 464 | 0.010 |
Why?
|
Carcinoembryonic Antigen | 1 | 2004 | 337 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2009 | 1386 | 0.010 |
Why?
|
Maximum Tolerated Dose | 1 | 2005 | 883 | 0.010 |
Why?
|
Body Fluids | 1 | 2004 | 320 | 0.010 |
Why?
|
Partial Thromboplastin Time | 1 | 2003 | 204 | 0.010 |
Why?
|
Quality Improvement | 1 | 2017 | 3801 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2013 | 2576 | 0.010 |
Why?
|
Rural Population | 1 | 2012 | 2285 | 0.010 |
Why?
|
Vitamin K 1 | 1 | 2001 | 47 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8529 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3688 | 0.010 |
Why?
|
Poverty | 1 | 2013 | 2698 | 0.010 |
Why?
|
Long-Term Care | 1 | 2005 | 633 | 0.010 |
Why?
|
Cobalt Radioisotopes | 1 | 2000 | 75 | 0.010 |
Why?
|
Half-Life | 1 | 2001 | 651 | 0.010 |
Why?
|
Time | 1 | 2002 | 546 | 0.010 |
Why?
|
Endosonography | 1 | 2004 | 609 | 0.010 |
Why?
|
Child, Preschool | 2 | 2013 | 42230 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2012 | 3085 | 0.010 |
Why?
|
Probability | 1 | 2005 | 2477 | 0.010 |
Why?
|
Benchmarking | 1 | 2006 | 1045 | 0.010 |
Why?
|
Patient Compliance | 1 | 2010 | 2690 | 0.010 |
Why?
|
Infant | 2 | 2013 | 36192 | 0.010 |
Why?
|
Preoperative Care | 1 | 2008 | 2242 | 0.010 |
Why?
|
Forecasting | 1 | 2008 | 2928 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2000 | 882 | 0.010 |
Why?
|
Antifibrinolytic Agents | 1 | 2001 | 292 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2003 | 2219 | 0.010 |
Why?
|
Insulin | 1 | 2012 | 6596 | 0.010 |
Why?
|
Sleep | 1 | 2013 | 4768 | 0.010 |
Why?
|
Drug Monitoring | 1 | 2003 | 962 | 0.010 |
Why?
|
Hypertension | 1 | 2017 | 8540 | 0.010 |
Why?
|
Recurrence | 1 | 2009 | 8465 | 0.010 |
Why?
|
Acute Disease | 1 | 2006 | 7237 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2007 | 1940 | 0.010 |
Why?
|
Attitude to Health | 1 | 2003 | 2025 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81525 | 0.010 |
Why?
|
Risk | 1 | 2006 | 9610 | 0.010 |
Why?
|
Social Support | 1 | 2003 | 2171 | 0.010 |
Why?
|
Visual Fields | 1 | 2000 | 1062 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2000 | 1958 | 0.010 |
Why?
|
Visual Acuity | 1 | 2000 | 2672 | 0.010 |
Why?
|
Animals | 1 | 2021 | 168459 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2008 | 26198 | 0.000 |
Why?
|
Radiotherapy | 1 | 1995 | 1499 | 0.000 |
Why?
|